Rendon, Yvette Maris .
HRN: 27-86-16 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2025
AMPICILLIN 1GM (VIAL)
10/12/2025
10/19/2025
IV
2 Grams
Q6
Prom X5 Hrs
Checking Final Appropriateness
10/12/2025
CEFUROXIME 500MG (TAB)
10/12/2025
10/18/2025
ORAL
500mg
2 Times A Day
Premature Rupture Of Membranes
Checking Final Appropriateness